Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues

被引:4
作者
Curione, Mario [1 ]
Di Bona, Simonetta [1 ]
Amato, Silvia [1 ]
Turinese, Irene [1 ]
Tarquini, Giovanna [1 ]
Gatti, Alessandra [1 ]
Mandosi, Elisabetta [1 ]
Rossetti, Marco [1 ]
Varrenti, Marisa [1 ]
Salvatore, Stephanie [1 ]
Baiocco, Erika [1 ]
Morano, Susanna [1 ]
机构
[1] Univ Roma La Sapienza, Rome, RM, Italy
关键词
Type; 2; diabetes; Secretagogues; Metformin; ECG; QT; Arrhythmias; FOLLOW-UP; INTERVAL; MELLITUS; GLIBENCLAMIDE; PROLONGATION; DISPERSION; MORTALITY; SELECTIVITY; PREDICTORS; DURATION;
D O I
10.1007/s00592-012-0438-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with type 2 diabetes are at increased susceptibility to a prolonged QT interval. Furthermore, insulin secretagogues, drugs used to treat diabetes, may prolong QT interval and provoke arrhythmias. We evaluated whether secretagogues can affect QTc interval during cardiac stress test in 20 patients with type 2 diabetes treated with secretagogues. ECG stress test was performed in all patients. QTc interval was calculated both before cardiac stress test (BCST) and at acme of cardiac stress test (ACST). Diabetic patients treated with secretagogues showed longer QTc-ACST values than those treated with metformin only. QTc-ACST values resulted shorter than QTc-BCST values in control group. Diabetic patients treated with secretagogues showed QTc-ACST values significantly longer than QTc-BCST values. In our study, diabetic patients treated with secretagogues did not show the QTc physiologic decrease that is a protective against arrhythmias. These results suggest to evaluate, in these patients, QT length, even during routine cardiac stress test.
引用
收藏
页码:31 / 33
页数:3
相关论文
共 16 条
[1]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[2]   Prognostic value of QT interval parameters in type 2 diabetes mellitus - Results of a long-term follow-up prospective study [J].
Cardoso, CRL ;
Salles, GF ;
Deccache, W .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (04) :169-178
[3]   QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes [J].
Christensen, PK ;
Gall, MA ;
Major-Pedersen, A ;
Sato, A ;
Rossing, P ;
Breum, L ;
Pietersen, A ;
Kastrup, J ;
Parving, HH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2000, 60 (04) :323-332
[4]   ACC/AHA 2002 guideline update for exercise testing: Summary article [J].
Gibbons, RJ ;
Balady, GJ ;
Bricker, JT ;
Chaitman, BR ;
Fletcher, GF ;
Froelicher, VF ;
Mark, DB ;
McCallister, BD ;
Mooss, AN ;
O'Reilly, MG ;
Winters, WL ;
Gibbons, RJ ;
Antman, EM ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Hiratzka, LF ;
Jacobs, AK ;
Russell, RO ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (08) :1531-1540
[5]   The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications - Report on a Policy Conference of the European Society of cardiology [J].
Haverkamp, W ;
Breithardt, G ;
Camm, AJ ;
Janse, MJ ;
Rosen, MR ;
Antzelevitch, C ;
Escande, D ;
Franz, M ;
Malik, M ;
Moss, A ;
Shah, R .
EUROPEAN HEART JOURNAL, 2000, 21 (15) :1216-1231
[6]  
IKEDA T, 1994, DIABETES METAB, V20, P565
[7]   The effect of acute hyperglycaemia on QTc duration in healthy man [J].
Marfella, R ;
Nappo, F ;
De Angelis, L ;
Siniscalchi, M ;
Rossi, F ;
Giugliano, D .
DIABETOLOGIA, 2000, 43 (05) :571-575
[8]   Differential effect of Glyburide (glibenclamide) and metformin on QT dispersion:: A potential adenosine triphosphate sensitive K+ channel effect [J].
Najeed, SA ;
Khan, LA ;
Molnar, J ;
Somberg, JC .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1103-1106
[9]   Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes - The strong heart study [J].
Okin, PM ;
Devereux, RB ;
Lee, ET ;
Galloway, JM ;
Howard, BV .
DIABETES, 2004, 53 (02) :434-440
[10]   The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium [J].
Quast, U ;
Stephan, D ;
Bieger, S ;
Russ, U .
DIABETES, 2004, 53 :S156-S164